Medicare utilization — DEBORAH MAJCHEL KOSS (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | 23,730 | 20 | $0 | $188,920 |
| J0897 | Injection, denosumab, 1 mg | 6,360 | 69 | $0 | $116,789 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 1,193 | 528 | $0 | $107,130 |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | 814 | 814 | $0 | $29,573 |
| 36415 | Insertion of needle into vein for collection of blood sample | 636 | 343 | $0 | $5,342 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·